Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.844 2 days ( 11.19 % )
Last Price $0.86 -11.19 %
High/ Low $0.84 - $0.99 25.94%
Chg 7 Days 9.74 % $0.786 $0.86
Chg 30 Days -11.03 % $0.97 $0.86
Chg 12 mos -93.49 % $13.26 $0.86
Trend - 3 mos -70.06 % Width: 151.43 %
Trend - 12 mos -56.53 % Width: 3071.28 %
Pred. range - 3 mos $0.112 - $0.280 -87.07 % - -67.49 %
Pred. range - 12 mos $0.187 - $5.94 -78.29 % - 588.41 %
Short mv avg 3 mos Sell 2023-09-28 - 2 days
Long mv avg 3 mos Sell 0000-00-00 - N/A days
Short/Long mv avg 3 mos Sell 0000-00-00 - N/A days
Short mv avg 12 mos Sell 2023-09-28 - 2 days
Long mv avg 12 mos Sell 2023-04-21 - 112 days
Short/Long mv avg 12 mos Sell 2023-04-13 - 118 days
Pivot Short Buy 2023-09-22 - 6 days
Bollinger Buy 2023-06-26 - 68 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT